MedPath

Trial to Reduce Hospitalizations in Children With Medical Complexity

Phase 2
Completed
Conditions
Chronic Illness
Interventions
Behavioral: Routine Care
Behavioral: Plans of Action and Care Transitions
Registration Number
NCT02277327
Lead Sponsor
University of California, Los Angeles
Brief Summary

The investigators hypothesize that an intervention, within an established patient-centered medical home, aimed at reducing modifiable risks for hospitalization, can decrease hospital utilization among medically complex children.

Detailed Description

The investigators will pilot test an intervention that includes contingency planning and care transitions within an established medical home program caring for children with medical complexity. Children with medical complexity receiving care within the UCLA Medical Home Program will be randomized to the pilot intervention or usual medical home care. The primary goal will be to reduce admissions and readmissions in the intervention group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Children ages 0 to 17 years old who are enrolled in the Pediatric Medical Home Program at UCLA
  • English and Spanish-speaking only
Read More
Exclusion Criteria
  • Children older than 17 years old who are enrolled in the Pediatric Medical Home Program
  • Non-English and Non-Spanish speakers
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Routine CareRoutine CareSubjects randomized to the "routine care" group will continue to receive their usual care from the Pediatric Medical Home Program at UCLA
InterventionPlans of Action and Care TransitionsSubjects randomized to the "intervention group" will participate in a bundled intervention that includes action planning and care transitions (for those hospitalized during the study period)
Primary Outcome Measures
NameTimeMethod
(2) preventable admissions, defined by 2 independent physicians blinded to study assignment as an admission due primarily to one of the preventable factors identified from Phase 1 of the study18 to 24 months
(1) number of all-cause admissions, defined as any admission occurring during the study period18 to 24 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UCLA

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath